ibrutinib,rituximab
abbvie,janssen
['imbruvica', 'mantle,(-dismantle)', 'lymphoma']
results of a large randomized trial support the inclusion of #ibrutinib (#imbruvica) to the standard first-line treatment of younger patients with mantle cell #lymphoma, reported martin dreyling, md, phd, at #ash22. 
Follow for #oncology news and coverage of all major oncology meetings! Peer-reviewed and oncologist-trusted.

@MedPageToday | #OncTwitter